BPG is committed to discovery and dissemination of knowledge
Featured Articles
6/24/2024 11:53:17 AM | Browse: 253 | Download: 828
 |
Received |
|
2024-01-28 17:21 |
|
Peer-Review Started |
|
2024-01-28 17:21 |
|
First Decision by Editorial Office Director |
|
2024-03-05 04:50 |
|
Return for Revision |
|
2024-03-05 04:50 |
|
Revised |
|
2024-04-02 13:05 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-04-11 02:33 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-04-11 07:31 |
|
Articles in Press |
|
2024-04-11 07:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-27 15:42 |
|
Publish the Manuscript Online |
|
2024-06-24 10:06 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Review |
| Article Title |
Harnessing immunity: Immunomodulatory therapies in COVID-19
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tsvetelina Velikova, Hristo Valkov, Anita Aleksandrova, Monika Peshevska-Sekulovska, Metodija Sekulovski and Russka Shumnalieva |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria |
BG-RRP-2.004-0008 |
|
| Corresponding Author |
Russka Shumnalieva, MD, PhD, Adjunct Associate Professor, Department of Rheumatology, Clinic of Rheumatology, University Hospital "St. Ivan Rilski", Medical University-Sofia, Urvich Street 13, Sofia 1612, Bulgaria. rshumnalieva@yahoo.com |
| Key Words |
Immunomodulation; COVID-19; Severe acute respiratory syndrome coronavirus 2; Immunotherapy; Antiviral immune response; Cytokine storm; Adaptive immunity; Therapeutic strategies; Immune modulators; Viral infection; Host immune response |
| Core Tip |
Effective management of coronavirus disease 2019 (COVID-19) requires a nuanced approach that harnesses the host’s immune response Immunomodulatory therapies play a pivotal role in fine-tuning the immune system, striking a balance between defense and avoiding excessive inflammation. In line with this, increased precision in targeting specific immune pathways, alongside personalized treatment strategies, holds promise in optimizing outcomes for COVID-19 patients. This paper explores the evolving landscape of immunomodulation, emphasizing its potential as a crucial component in the therapeutic arsenal against the virus. |
| Publish Date |
2024-06-24 10:06 |
| Citation |
Velikova T, Valkov H, Aleksandrova A, Peshevska-Sekulovska M, Sekulovski M, Shumnalieva R. Harnessing immunity: Immunomodulatory therapies in COVID-19. World J Virol 2024; 13(2): 92521 |
| URL |
https://www.wjgnet.com/2220-3249/full/v13/i2/92521.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v13.i2.92521 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
